An interventional study of Protein and Walking in Overweight, Obesity and Abdominal Obesity, sponsored by University of Erlangen-Nürnberg Medical School. Completed at 1 site in Germany. Open to female participants aged 25 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-03-18.
Sponsored by University of Erlangen-Nürnberg Medical School · Not applicable, Interventional, and Prevention
The present study aimed to determine the effect of different interventions on lean body mass maintenance under weight loss conditions in overweight and obese premenopausal women. Three study groups were implemented: (1) Protein supplementation (only) group (2) Protein supplementation and walking intervention (3) Protein supplementation, walking and WB-EMS-application. All protocols were applied for 16 week of intervention.
A energy deficit of 500 kcal/d was intended however while group (1) focus consistently on energy restriction (500 kcal/d), in group (2) and (3) a combined physical activity (i.e. walking with a volume representing 250 kcal/d) and energy restriction (250 kcal/d) protocol was applied. Total protein uptake including protein supplementation was calculated to average around 1.2 g/kg body mass per day in groups (1) and 1.5 g/kg body mass/d in group (2) and (3). WB-EMS was applied 1.5x 20 min/week (i.e. each Tuesday and every second Thursday).
Primary study endpoint was LBM as determined by Dual Energy x-Ray Absorptiometry.
3,767 studies on the registry are indexed under Overweight; 863 are open to participants now.
This study's enrollment of 30 is below the median of 73 across 3,263 interventional studies indexed under Overweight.
Browse Overweight studies →University of Erlangen-Nürnberg Medical School is the lead sponsor of 275 studies on the registry; 52 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Energy restriction of 500 kcal/d and total Protein Uptake (including Supplementation) of 1.2 g/kg body mass/d
Dietary Supplement: Protein
Energy restriction of 250 kcal/d, increased energy consumption by walking (250 kcal/d) and total protein uptake (including supplementation) of 1.5 g/kg body mass/d
Dietary Supplement: Protein · Behavioral: Walking
Energy restriction of 250 kcal/d, increased energy consumption by walking (250 kcal/d), total protein uptake (including supplementation) of 1.5 g/kg body mass/d and WB-EMS application 1,5x 20 min/week
Dietary Supplement: Protein · Behavioral: Walking · Behavioral: WB-EMS application
Protein supplementation 1.2 or 1.5 g/kg body mass/d
Walking with a volume corresponding to 250 kcal/d
WB-EMS application 1.5x 20 min/week
Lean body mass
Fat and bone free total body mass in kg
Time frame: changes from baseline to 16 week follow-up
Total Body Fat
Total Body Fat in kg
Time frame: changes from baseline to 16 week follow-up
Total Body Fat Rate
Percent Total Body Fat Rate
Time frame: changes from baseline to 16 week follow-up
Appendicular Skeletal Muscle Mass
Lean Body Mass of the upper and lower limbs in kg
Time frame: changes from baseline to 16 week follow-up
Visceral Body Fat
Total visceral body fat in kg
Time frame: changes from baseline to 16 week follow-up
Trunk fat
Total trunk fat in kg
Time frame: changes from baseline to 16 week follow-up
Metabolic Syndrome Z-Score
Summarized Z-Score that included Z-Scores of blood lipids, lipoproteins, glucose, resting blood pressure and waist circumference. Cut-offs based on the definition of the International Diabetes Federations
Time frame: changes from baseline to 16 week follow-up
This study is completed, as verified in Mar 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Erlangen-Nürnberg Medical School →